MedTrace Logo

An Innovative Taping Technique for Improved Intravenous (IV) Catheter Securement

NCT05948878 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2026-04-15

Study results available
· View outcomes & findings →

Summary

This is a prospective, single-blinded, randomized study to assess the ability of taping methods used to secure intravenous (IV) catheters to resist the IV from being pulled away from the skin. Participants will have IV catheters taped on top of the skin (without insertion into the skin) using three taping methods, BCH Emergency Department (BCH ED), Chevron, and our novel method. Six measurements will be obtained per subject (3 random taping methods measuring their resistance to force in two directions, retrograde direction or towards the wrist and 90-degree angle to the arm).

Conditions

  • Dislodged Catheter
  • Catheter Related Complication

Interventions

DEVICE

Novel Taping Method

Subjects will be asked to have the novel taping method placed on their left and right antecubital fossa region, superficially taping an IV catheter.

DEVICE

BCH Emergency Department Taping Method

Subjects will be asked to have the BCH emergency department taping method placed on their left and right antecubital fossa region, superficially taping an IV catheter.

DEVICE

Chevron Taping Method

Subjects will be asked to have the Chevron taping method placed on their left and right antecubital fossa region, superficially taping an IV catheter.

Sponsors & Collaborators

Principal Investigators

  • Pete Kovatsis, MD · Boston Children's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-28
Primary Completion
2023-11-09
Completion
2023-11-09
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05948878 on ClinicalTrials.gov